The European Union announces a new “million” deal for the Corona vaccine

<div id="firstBodyDiv" data-bind-html-content-type="article" data-bind-html-compile="article.body" data-first-article-body="

The two companies will be supplied European Union With up to 300 million doses of The vaccine, Which you hope will get approved for use next year.

This deal comes after an agreement between the European Union and the company "AstraZeneca" To reserve 400 million doses of the vaccine being developed in cooperation with Oxford university British.

When it gets millions of doses of the vaccine, the European Commission will finance part of the upfront costs borne by vaccine producers, she said. "Reuters".

He called the general manager To the World Health OrganizationTedros Adhanom Ghebreyesus, Monday, nations of the world join the plan "Kovacs" Before the deadline expires on Friday, to ensure that any vaccine can be distributed novel coronavirus Fairly and effectively.

Tedros said at a regional organization event for Europe that was broadcasted online: "If people in middle- and low-income countries do not get vaccinated, the virus will continue to kill people, and global economic recovery will be delayed.".

So far, 92 low-income countries are seeking help through a scheme "Kovacs"It is part of WHO’s Act Accelerator umbrella to promote the development of vaccines, treatment methods and diagnostics to combat the COVID-19 epidemic.

About 80 of the highest-income countries have expressed interest in the initiative, but many of them must confirm their intention to join by the end of this week.

According to the United Nations Children’s Fund "UNICEF"So, 28 pharmaceutical companies in ten countries are ready to produce unprecedented quantities of vaccines over the next two years to fight a pandemic Covid-19.

Intervals "UNICEF" 28 vaccine manufacturers have revealed annual production plans for COVID-19 vaccines through 2023.

He revealed his evaluation "UNICEF" للسوق "Manufacturing companies are ready to mass-produce unprecedented quantities of vaccines over the next year or two".

However, companies indicated that expectations "It largely depends on, among other things, the success of clinical trials, the conclusion of agreements for pre-purchase, confirmation of funding, and the simplification of regulatory matters and registration methods.".

وينبع دور "UNICEF" New in plan "Kovacs" Who positioned it as the largest single buyer of vaccines in the world.

وذكرت United Nations organization It purchases more than two billion doses of vaccines annually for periodic vaccinations and disease outbreak control on behalf of nearly 100 countries.

And my company already "Sanofi" And"GlaxoSmithKline" That they signed a deal worth 2.1 billion dollars, to provide the United States with 100 million doses of the expected vaccine, with an option that would enable Washington to purchase 500 million additional doses, in addition to a deal with Britain to support it with 60 million doses.

“>

The two companies will be supplied European Union With up to 300 million doses of The vaccine, Which you hope will get approved for use next year.

This deal comes after the agreement of the European Union and the company.AstraZeneca“To reserve 400 million doses of the vaccine that is being developed in cooperation with Oxford university British.

And when it gets millions of doses of the vaccine, the European Commission will finance part of the initial costs borne by vaccine producers, according to “Reuters”.

He called the general manager To the World Health OrganizationTedros Adhanom Ghebreyesus, Monday, countries of the world join the “Kovacs” plan before the deadline expires on Friday, to ensure the distribution of any vaccine to prevent novel coronavirus Fairly and effectively.

Tedros said in a regional event of the Organization for Europe that was broadcast online: “If people in middle and low-income countries do not get vaccinations, the virus will continue to kill people, and the global economic recovery will be delayed.”

So far, 92 low-income countries are seeking help through the “Kovacs” plan, which is part of the organization’s (Act Accelerator) umbrella to promote the development of vaccines, treatment methods and diagnostics to combat the COVID-19 epidemic.

About 80 of the highest-income countries have expressed interest in the initiative, but many of them must confirm their intention to join by the end of this week.

According to the United Nations Children’s Fund “UNICEF“28 pharmaceutical companies in ten countries are ready to produce unprecedented quantities of vaccines over the next two years to fight a pandemic Covid-19.

Interval “UNICEF“28 vaccine manufacturers have revealed annual production plans for COVID-19 vaccines through 2023.

A UNICEF market assessment revealed that “manufacturing companies are ready to mass produce unprecedented quantities of vaccines over the next year or two.”

However, the companies indicated that expectations “depend to a large extent on, among other things, the success of clinical trials, the conclusion of agreements for pre-purchase, confirmation of funding, and simplification of regulatory matters and registration methods.”

UNICEF’s new role in the Kovacs plan stems from its position as the largest single buyer of vaccines in the world.

وذكرت United Nations organization It purchases more than two billion doses of vaccines annually for periodic vaccination and disease outbreak control on behalf of nearly 100 countries.

“Sanofi” and “GlaxoSmithKline” previously signed a deal worth $ 2.1 billion to supply the United States with 100 million doses of the expected vaccine, with an option that would enable Washington to purchase 500 million additional doses, in addition to a deal with Britain to support it with 60 million doses. .

– .